Introduction
============

The most commonly used phenotype in research on aging is the age of death of model organisms. Death, the end point of aging, is unambiguously defined and occurs universally in living organisms. Changes in lifespan between groups with identical genetic background and environmental conditions except for one defined difference can be used to demonstrate the effect of this factor on survival. Survival analysis is not only used for research in aging, but also in research on new treatments for fatal diseases such as cancer.

Traditionally in research on aging, survival data from lifespan experiments are only analysed in the original study and not collected and stored together. Use beyond the primary study is generally limited to comparing changes in mean lifespan or other high-level summary statistics. It is often argued that valid comparisons of survival data between experiments are prevented by the fact that environmental factors influence survival and the survival effects of interventions. Thus, collecting survival data would not be useful. While variation in environmental factors limits the possibilities to compare data, it does not prevent reanalysing data from individual experiments in new or different ways, nor does it prevent comparing data with identical conditions. Multifactorial survival analysis methods such as Cox proportional hazard or accelerated failure time models (Cox, [@b5]) taking into account variation in multiple specified conditions can also be used.

While human deaths are precisely recorded in the developed world and mortality data are available through various databases such as the Human Mortality Database (<http://www.mortality.org>), there has been no database for survival data from non-human animals, including model organisms. As a result, these valuable data which are key to research on aging and are recorded in numerous laboratories around the world, sometimes as a result of year-long efforts, are currently not publicly available nor accessible and prone to be lost when researchers move on to new positions. Given the central importance of this phenotype for research on aging, researchers would ideally be able to mine the collective knowledge, explore data of individual studies alone and in the context of other studies, combine information from multiple trials and reinvestigate existing data in new ways. For example, alternative visualisation of the same data has fuelled scientific discussion about a recent aging study in *Drosophila* (Giannakou *et al*., [@b7]; Tatar, [@b28]).

While the statistical framework for single study survival analysis is well developed and numerous textbooks are available (Kalbfleisch & Prentice, [@b17]; Kleinbaum & Klein, [@b19]), the framework is far less developed for jointly analysing survival data from multiple studies while accounting for differences in multiple factors, incomplete information and potential additional unknown factors. The lack of a database for survival data in model organisms has hampered the development of statistical methods for survival meta-analysis and the evaluation of existing methods for certain settings, because it requires the tedious process of collecting an appropriate set of survival data. While such efforts exist (Swindell, [@b26]), examples remain rare. The necessity to have survival data accessible has been also been acknowledged by the leading journal in aging research, Aging Cell, which requires authors to provide their raw survival data in the supplement, 'to allow replication of the presented analysis and to facilitate independent analysis and cross-study comparisons' (Aging Cell Author Guidelines). We thus created a new database and online resource for survival data in animals called SurvCurv. It contains manually curated survival data annotated with public database identifiers, making these data truly accessible. The platform allows direct analyses of the provided data and all data can be downloaded to be used for further analyses with other software. Finally, we illustrate how a collection of survival data on aging can be used to introduce the concept of pooled historical controls to research on aging.

Results
=======

SurvCurv database content
-------------------------

We have created the new database and online resource SurvCurv, which currently contains public survival records of 99 496 individual animals: 10 706 *Caenorhabditis elegans*, 84 938 *Drosophila melanogaster* and 3852 individuals of other species. These records belong to a total of 1063 cohorts from 29 studies (see list of citations in [Data S1](#SD1){ref-type="supplementary-material"}). They include survival under various conditions such as different temperatures, dietary conditions and mating paradigms, as well as genetic alterations or administration of drugs. Additional unpublished or copyrighted data have been included with password-restricted access and will be released upon publication or copyright clearance.

The maximum *Drosophila* lifespan recorded in SurvCurv is 147 days {a female fly of the Dahomey strain kept at 18 °C \[Iqbal *et al*. ([@b15]), SurvCurv ID: 204\]}, and the maximum recorded for *C. elegans* is 53 days {rrf-3(pk1426) daf-2 and smg-1 RNAi \[Masse *et al*. ([@b20]), SurvCurv ID: 892\]}. The maximum change in median lifespan between control and treatment in *Drosophila* is 67 days, or 110%, for a change in temperature from 25 to 18 °C \[Iqbal *et al*. ([@b15]), SurvCurv IDs: 202 and 204\] and the second largest change is 26.5 days, corresponding to a 53% increase, for a homozygote knock-out of *Drosophila* insulin-like peptides 2-3,5 \[Grönke *et al*. ([@b11]), SurvCurv IDs: 427 and 426\]. The largest single cohort contains 3177 individuals {WT female flies at 27 °C \[Jacobson *et al*. ([@b16]), SurvCurv ID: 197\]} and the oldest cohorts currently recorded are from 10 May 1993 \[Chapman *et al*. ([@b4]), SurvCurv IDs: 979-986\].

SurvCurv web interface
----------------------

The new database and online resource SurvCurv is accessible through the web interface at <http://www.ebi.ac.uk/thornton-srv/databases/SurvCurv/> (Fig. [1](#fig01){ref-type="fig"}). The web interface enables the user to browse the database content, analyse it online, download data sets for offline analysis, and to submit data to the database. In addition, the direct analysis interface allows upload of the user\'s own survival data for analysis and visualisation. These data are transferred to the SurvCurv server via a secure internet connection and only used for the selected analyses. They are not permanently stored, made available to anybody else or included in the database. If the user would like to submit data after having analysed them, this has to be carried out separately via the submission page and the author will be contacted to confirm release before making any submitted data available through the database. Statistical descriptors and tests can be directly computed on user data, and data available through the database can be incorporated in any analysis. The database content can be browsed or searched by a simple text box search as well as an advanced search for specific fields. Identifiers as well as plain-text descriptors can be searched using the simple search feature. Each cohort of animals has been manually curated and annotated with a short name, an optional longer description including remarks, a reference (usually a publication), the species, strain and gender, the experimental conditions and treatments applied as well as its relationship with other cohorts. Furthermore, precalculated descriptive statistics and parameters of six common mathematical mortality models, detailed under Statistical Features below, are provided (Fig. [1](#fig01){ref-type="fig"}B). Besides the annotated related cohorts, the database content can be explored based on various similarity measures through the similarity search available in the 'details' section of each cohort. Similarity can be based on any descriptive statistical measure displayed, such as the median or the parameters of the fitted mathematical models. This explorative tool enables users to find other cohorts, similar with respect to the property of interest and can lead to the discovery of unexpected connections. These can prompt a more detailed analysis and even further experiments.

![(A) Screenshot of the front page of the SurvCurv Website (B) Screenshot of a detailed cohort information display example.](acel0012-0910-f1){#fig01}

Visualisation features
----------------------

Cohorts uploaded for direct analysis, cohorts from the database as well as mathematical models can all be visualised in four common ways: survival curves (Fig. [2](#fig02){ref-type="fig"}A), death curves (Fig. [2](#fig02){ref-type="fig"}B), also called cumulative incidence curves, incidence curves (Fig. [2](#fig02){ref-type="fig"}C) and mortality curves, also called hazard plots (Fig. [2](#fig02){ref-type="fig"}D). Each of these representations has advantages in illustrating certain properties of the data. Survival curves represent the percentage of the population alive over time, which is a cumulative measure, as are death curves, showing the percentage of the population that has already died. The other two curves are noncumulative and show the distribution of death events or incidences (incidence curve) and the mortality risk over time. While survival curves are the most common graphical representation, it is usually advised to also examine the corresponding mortality plots to avoid missing temporal variation, which can lead to controversies (Giannakou *et al*., [@b7]; Tatar, [@b28]).

![Survival data visualisations. (A) Survival curve -- shows the cumulative probability of surviving over time, which is equivalent to the percentage of the population alive. (B) Death curve -- shows the cumulative probability of dying over time, corresponding to the percentage of the population which has already died. This curve is sometimes also called cumulative incidence curve. (C) Incidence plot -- shows the distribution of death events or incidences over time. (D) Mortality plot -- shows the negative logarithm of the noncumulative probability of death, that is, hazard rate, on a log scale over time. It represents the probability of dying in that time frame, given an individual has survived until the beginning of the time frame. \[Example: Partridge *et al*. ([@b22]), SurvCurv:486\].](acel0012-0910-f2){#fig02}

While these plots show the absolute characteristics nicely, the difference between control and treatment or between two different conditions, which is usually the question of interest, is only indirectly represented. Especially when dealing with results from different studies, it is important to examine the control-treatment differences, rather than the absolute lifespan variations, which are influenced by numerous other effects, such as temperature or food type. We thus defined four new plots called difference plots. Each of these plots is based on one of the common plots mentioned before, but instead of using the absolute values it shows the differences between pairs of 'treatment' and control cohorts on the *y*-axis. In difference survival curves, positive values indicate a survival advantage of the treatment compared to the control, while a disadvantage results in the curve falling below the zero line. Difference plots cannot only be based on survival curves, but also on mortality curves, showing relative mortality differences. All these difference plots also support the use of mathematical models in addition to or instead of survival data. This can be useful for exploring the differences between cohorts via the corresponding models. Alternatively, the differences between two mathematical models of the same survival data can be visualised in the same way.

The web service offers additional plotting options like different output formats such as PDF or SVG, as well as the style to connect the individual measurement points. For incidence, mortality and all difference plots, a sliding window smoothing can be applied, and a log scale for the time axes can be used instead of the normal linear scale for all plots. Further options include the ability to automatically combine annotated replicates, to add 'historical controls', or create meta-cohorts based on user-defined criteria.

Historical controls
-------------------

Historical controls are a concept already commonly used in toxicity and cancerogenicity studies (Keenan *et al*., [@b18]) to put individually measured lifespans into a bigger picture by a three-way comparison between historical control, measured control and measured treatment condition. This comparison clearly indicates whether the measured control strongly deviates from the average control, which would suggest that extra caution is necessary in interpreting the results and comparing them to other studies. Through collecting survival records in SurvCurv, we are able to combine controls of identical or highly similar conditions to define average pooled survival curves \[see [@b33] for further details\]. We refer to these as 'historical controls' in agreement with the established terminology in the fields of toxicity and cancerogenicity. We have defined historical controls for wDah and w1118 for defined conditions, which are readily available through the web interface. Moreover, users can define their own historical controls, or meta-cohorts, based on their own criteria.

An example where historical controls might have been helpful is the study of dFOXO overexpression (Giannakou *et al*., [@b8]; Fig. [3](#fig03){ref-type="fig"}). Looking only at the measured control and treatment, the conclusion is a clear increase in lifespan when overexpressing dFOXO, and further studies (Hwangbo *et al*., [@b13]; Giannakou *et al*., [@b9]) support the general statement that dFOXO overexpression can extend lifespan. However, taking into account the survival curve of pooled controls of similar conditions (in this case once mated female wDah flies at 25 °C fed 1SY food), it is quite clear that both measured control and treatment have shorter survival than the historical control. The positive effect of dFOXO overexpression could therefore additionally be seen as partially rescuing some unknown negative effect on lifespan which occurred in the experiment. Further investigation of such findings at the time of the experiment could help uncover unknown interactions of different modulators of aging.

![Survival curves for dFOXO overexpression (dashed) (SurvCurv:490+500), measured control (solid) (SurvCurv:494+504) and historical control with ostensibly inactive genetic constructs from pooled control cohorts of once mated female wDah *Drosophila melanogaster* at 25 °C fed 1SY food (dotted).](acel0012-0910-f3){#fig03}

A second example where historical controls could have been useful is a study on IRS2 knock-out mice (Taguchi *et al*., [@b27]), which found a lifespan increase in the KO mice compared to their controls. This result has been criticised because the control showed an unusual survival pattern and an independent study of the same KO mice with a similar study design found no significant increase in lifespan (Selman *et al*., [@b25]). The KO lifespan measured in the second study was in good agreement with the one measured in the first study, but the lifespans of the controls were very different. A well-defined historical control matching the experimental conditions could help to settle the argument, by clearly positioning both experiments in context to previous studies.

Statistical features
--------------------

In addition to the visualisations described above, the database provides various numerical summaries: the number of observed individuals, the number of censored data points, as well as other descriptive statistics such as minimal, mean, median and maximal observed lifespan, but also variance and skewness.

Six common mathematical mortality models (Exponential model, Weibull model, Gompertz model, Gompertz-Makeham model, Logistic model and Logistic-Makeham model) have been fitted to each cohort where possible and can be plotted alone or together with the data. The relative goodness of fit measured by Akaike and Bayesian Information Criterion (AIC and BIC, respectively) values as well as a classical maximum-likelihood estimate together with the parameter values are provided. The mathematical mortality model that fits *Drosophila* survival data best according to AIC (and BIC criterion) is in most cases the Gompertz model \[35% of all cases (45% for BIC criterion)\], closely followed by the Weibull model \[29% (35% for BIC criterion)\], while for *C. elegans*, the Weibull model is fitting best in most cases \[51% of all cases (65% for BIC criterion)\] and the Gompertz is only the best model in ∼ 10% of the cases.

When plotting data through the web interface using any basic representation, the log-rank test (Harrington & Fleming, [@b12]) and generalised Wilcoxon test (Harrington & Fleming, [@b12]) for statistical difference between cohorts are applied and the results given below the plot. The log-rank test is more sensitive to survival differences between cohorts at later time points, while the generalised Wilcoxon test is more sensitive to differences at early time points. By default, both methods test whether all cohorts come from the same distribution, that is, are not different, but pairwise tests can be enabled in the advanced plotting options. The Wang-Allison test (Wang *et al*., [@b31]) for differences in maximal lifespan can also be activated there. Pairwise Fisher\'s exact tests (Fisher, [@b6]) for differences at a specified time point can be calculated, too. For difference plots, statistical descriptors such as the area under the curve or the area under the absolute curve are given for each curve.

Cox proportional hazards analysis
---------------------------------

SurvCurv also offers the possibility to analyse database data or uploaded data using the Cox proportional hazards (CoxPH) model (Cox, [@b5]), a statistical model of survival data with one or more covariates or factors, that is, for multiple conditions. It allows the user to identify which factors significantly contribute to the overall model and quantify their respective influences on the hazard rates in the model. An increased survival corresponding to a decreased mortality or hazard rate is indicated by an exp(coef) \< 1, with exp(coef) giving the relative mortality risk compared to the baseline. Importantly, the CoxPH model assumes that the hazard rates of the different conditions are proportional, that is, the mortality of all conditions are multiples of each other. This assumption thus has to be checked before each CoxPH analysis. SurvCurv automatically tests the assumption and presents the results of the tests, together with the CoxPH results and diagnostic plots of the assumption (see Fig. [4](#fig04){ref-type="fig"} for an example). It has to be noted that p-values of the proportional hazards tests, like of any other test, are strongly dependent on the sample size. Gross violations may not be statistically significant if the sample size is very small, and even slight violations, causing negligible errors in the estimated coefficients, may be highly significant if the sample size is very large. An estimate of the size of the deviations from the assumed independence, that is, no correlation (see Methods for details), is given by the respective correlation coefficients rho, which can thus be helpful in interpreting the test results. If the proportional hazards assumption has been rejected with noticeable deviations, alternative analysis such as accelerated failure time analysis (AFT) or Cox analysis using transformed or time-dependent co-variates might be necessary. These are currently not available in SurvCurv, but users requiring these analyses can download all data for use in their preferred full statistics program.

![Cox Proportional Hazards Diagnostic Plot Example showing the scaled Schoenfeld residuals plotted against the transformed time. Additionally shown are a nonlinear fitted line of the data (black solid) and a horizontal line \[dotted blue (grey in print version)\] corresponding to the determined Cox coefficient. There should be no clear overall increasing or decreasing tendency and the fitted nonlinear line should roughly follow the dotted horizontal line. This example shows a very good case. (The example is the diagnostic plot of the UAS-factor taken from CoxPH analysis of SurvCurv:164, 166, 168, 170 (Ikeya *et al*., [@b14]) using factors for GAL4, UAS and GAL4-UAS interaction.)](acel0012-0910-f4){#fig04}

One possible application of the CoxPH model is to evaluate UAS/GAL4-based lifespan experiments in *Drosophila*. In the UAS/GAL4 transcriptional system (Brand & Perrimon, [@b2]), two transgenic elements are used to express a gene of interest. The upstream activator sequence (UAS) is a promoter region with GAL4 binding sites followed by a transgene of interest and the GAL4-element encodes the yeast transcriptional activator GAL4 driven by a *Drosophila* promoter. Separately, the two transgenes should have no effect, jointly; however, the transgene of interest should be transcribed and might influence longevity. The classical approach to evaluating the experiments is to test for a significant change in lifespan between a cohort containing only the UAS-construct and one containing both UAS- and GAL4-construct and a second test between a cohort containing only the GAL4-construct against the combined cohort. If both tests indicate a significant change, it is assumed that the transgene of interest is changing the survival. However, for this to be true, the GAL4-alone cohort and the UAS-alone cohort have to be also compared to the WT and show either no difference in lifespan or the combined differences to the WT have to be smaller than the difference between WT and lifespan of the cohort with both constructs. Otherwise, the change in lifespan is not due to the overexpression but the combination of the individual survival benefits of the construct insertions. While a simple test cannot check this complex condition, the CoxPH model can be used to evaluate this by determining the model for the four cohorts WT, UAS-alone, GAL4-alone, and both UAS and GAL4 using a UAS-GAL4-interaction term. If there is a change in survival which is due to the transgene of interest, the interaction term is significant and the coefficient quantifies the effect. An example is the overexpression of a dominant negative variant of the *Drosophila* insulin receptor InR (Ikeya *et al*., [@b14]) (SurvCurv Identifiers 164, 166, 168, 170). The test for the proportional hazard assumption has a global *P*-value = 0.04 and an average \|rho\| = 0.07, indicating that the assumption is not rejected with large deviation, so the model is applicable. The model shows that factors for presence of the GAL4-construct and presence of the UAS-construct are nonsignificant (*P*-values of 0.82 and 0.17, respectively), but the GAL4-UAS interaction term is highly significant (*P*-value = 1.6\*10^−12^). Moreover, the GAL4-UAS interaction term has a coefficient of −1.9 corresponding to strongly reduced mortality by the factor of 0.125, that is, a 8-fold reduction. This shows that the GAL4-construct alone and the UAS-construct alone do not change mortality significantly, but the interaction of the two constructs does. Other interesting applications might be the examination of interactions of different treatments, such as dietary restriction, drug administrations or mutations to discriminate between overlapping, independent and synergistic mechanisms \[see Ziehm *et al*. (this issue) for applications\].

Discussion
==========

Here, we introduced a new database and online resource for survival data in animals, especially model organisms. We have focussed our curation initially on *Drosophila* as a powerful tool for discovery and widely used model organism in research on aging, but we plan to increasingly include data from other organisms. The power and value of the database for the research community are vitally dependent on availability of the relevant data, which in turn depends on researchers supporting the database by contributing their data.

Survival analysis has existed for many decades and numerous statistical software packages, such as JMP or R, are available today offering different interfaces with varying functionalities. While a full statistical software will inevitably offer more possible analyses and features than a specialised online analysis resource, SurvCurv provides all commonly desired survival analysis functions. This includes true mortality plots that show the instantaneous, noncumulative hazards rates; a function not offered by JMP or basic R. Furthermore, SurvCurv is free to use and requires no setup or maintenance by the user. Recently, a different online analysis service for survival data, OASIS (Yang *et al*., [@b32]), has been published. Similarly to SurvCurv, it permits direct online analysis functionalities. While it offers some additional less common statistical tests, it lacks the important noncumulative mortality plots offered by SurvCurv. OASIS also does not allow for interactions terms in the Cox proportional hazards modelling nor is the proportional hazards assumption tested. Both of these crucial features are available in SurvCurv. Additionally, SurvCurv provides easy access to precalculated mortality models of six common forms. These models, including the Logistic--Makeham model, which can capture late-life mortality rate deceleration, are calculated by the highly regarded WinModest methodology. These are currently otherwise only available through R, whose use is very challenging for nonspecialist users. The main stronghold of SurvCurv, however, is not the pure analysis functionalities, but the freely available, collected and curated survival data, which can be analysed alone or in combination with new data provided by the user directly online. Furthermore, all data can be downloaded for analysis with other software or for testing new methodology, allowing any chosen analysis to be run.

Smart ways to take differences in control-lifespan into account are essential. The difference plots used here present a very basic means to do so. This approach has the advantage of being intuitively understandable and only dependent on the control and treatment and thus is independent of other potential pairs. The downside of this independence is that the individual differences are still not completely comparable and do not provide a statistical measure. More complex approaches calculating transformations that align the controls, which are then applied to the treatments, are desirable. As for multiple sequence alignment methods, survival alignment methods will certainly become more sophisticated. At the same time, new statistical tests for comparing lifespans between experiments which take into account the differences in the respective controls are vital. The development of such methods and tests is aided by the free SurvCurv database by providing readily available data for development and validation, thus abolishing the need for a cumbersome and time-consuming data-collection process.

Experimental procedures
=======================

Data gathering
--------------

We have contacted authors of publications from the last 2 years showing survival data and asked them for the corresponding numerical data. While we have focused our efforts so far on *Drosophila*, some data sets from other organisms have been included as well. A large proportion of the *Drosophila* data originates from the Partridge lab. Furthermore, a single study on baboons (Bronikowski *et al*., [@b3]) provided survival data, which was included in the nonpublic area of the database. This unexpected example proved that the design of the database is applicable to very different kinds of animals.

We also noticed that the information on the experimental conditions in the papers is incomplete in a non-negligible number of cases. Besides data provided to us by authors, we also explored the availability of data from supplementary files of articles. We retrieved limited amounts of survival data especially from the journal Aging Cell, which tries to increase accessibility of the data through their guidelines. While we are currently not able to republish these data through our database due to Aging Cell\'s copyright on these files, we hope to gain permission for it in the future.

All data in the public database are made available under a Creative Commons Attribution 3.0 Unported License (<http://www.creativecommons.org/licenses/by/3.0/>). This licence allows others to freely use, distribute, tweak, and build upon the database, even commercially, without any other restrictions than properly crediting the original work, that is, the original publication and the database.

Implementation
--------------

The data of SurvCurv are stored in a MySQL database, which allows the storage of animal counts as well as relative incidence rates, that is, computed survival rates. The internal structure enables not only the storage of survival data, but potentially also of other time-to-event data, by using different incidence types.

Data processing and insertion into the database was performed using multiple purpose-tailored scripts in python and R (R Development Core Team, [@b24]). All data were manually curated and annotated using public database identifiers, for example FlyBase (Tweedie *et al*., [@b30]) for fly genes and constructs and CHEBI (de Matos *et al*., [@b21]) for small molecules including drugs. Statistical descriptors were calculated using R taking into account censored observations. Mathematical mortality models were fitted to the individual data sets using the Survomatic R package (Bokov & Gelfond, [@b1]). This package includes an R port of the popular WinModest (Pletcher, [@b23]) software. The fitting procedure starts by fitting the exponential model with only one parameter, which can be calculated directly and then uses the parameter estimates of simpler models as starting points for fitting more complex models.

The web interface was implemented in PHP using an EBI framework and the Crystal Clear icon set by Everaldo Coelho as provided by Wikimedia Commons (<https://commons.wikimedia.org/wiki/Crystal_Clear>). The visualisation and survival analysis functionalities are realised via a server-side R script (R Development Core Team, [@b24]), using the R survival package (Therneau, [@b29]). The pairwise Fisher\'s exact test (Fisher, [@b6]) provided by R, and the log-rank test and Wilcoxon test provided by survdiff of the R survival package were used. The survdiff function implements the G-rho family of Harrington & Fleming ([@b12]), which is the log-rank test with ρ = 0, and with ρ = 1, it is equivalent to Peto and Peto\'s modification of the Gehan--Wilcoxon test. The Wang--Allison test (Wang *et al*., [@b31]) for differences in maximum lifespan was implemented in R.

SurvCurv uses the Cox proportional hazards model implementation of the survival package with the Efron approximation for ties. The test for the proportional hazards assumption is a chi-square test between the Kaplan--Meier transformed survival times and the Schoenfeld residuals implemented in cox.zph of the survival package (Grambsch & Therneau, [@b10]). The diagnostic plots show the scaled Schoenfeld residuals along with a fitted natural spline of 4 degrees of freedom and a horizontal line of the determined model coefficient.
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